Clinical Trials Directory

Trials / Completed

CompletedNCT01675986

Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
306 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The insertion of long-lasting intravenous device is done under local anesthesia. Currently, in the investigators hospital, no premedication is given to the patients. However, this procedure occurs in a particular emotional context related to the diagnosis of cancer or malign hemopathies. Therefore, administration of a sedative or anxiolytic drugs before the start of the procedure can be questionable. Hydroxyzine is the reference molecule for premedication because of its anxiolytic and anti-histaminic properties A new agent, pregabalin, shares also the same properties The main objective of this study was to compare the efficacy of pregabalin and hydroxyzine on the anxiety score as a premedication during the insertion of long-lasting intravenous device under local anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGhydroxyzine75 mg
DRUGPregabalin150 mg
DRUGLactose4 g

Timeline

Primary completion
2014-11-01
First posted
2012-08-30
Last updated
2016-10-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01675986. Inclusion in this directory is not an endorsement.